These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36828520)

  • 1. Gender and Drug-Resistant Tuberculosis in Nigeria.
    Oladimeji O; Atiba BP; Anyiam FE; Odugbemi BA; Afolaranmi T; Zoakah AI; Horsburgh CR
    Trop Med Infect Dis; 2023 Feb; 8(2):. PubMed ID: 36828520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chest X-ray Features in Drug-Resistant Tuberculosis Patients in Nigeria; a Retrospective Record Review.
    Oladimeji O; Adeniji-Sofoluwe AT; Othman Y; Adepoju VA; Oladimeji KE; Atiba BP; Anyiam FE; Odugbemi BA; Afolaranmi T; Zoakah AI
    Medicines (Basel); 2022 Sep; 9(9):. PubMed ID: 36135827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Resistance Patterns and Trends in Patients with Suspected Drug-Resistant Tuberculosis in Dalian, China: A Retrospective Study.
    Pan Y; Yu Y; Lu J; Yi Y; Dou X; Zhou L
    Infect Drug Resist; 2022; 15():4137-4147. PubMed ID: 35937782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
    PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with multidrug-resistant tuberculosis in South India.
    Shivekar SS; Kaliaperumal V; Brammacharry U; Sakkaravarthy A; Raj CKV; Alagappan C; Muthaiah M
    Sci Rep; 2020 Oct; 10(1):17552. PubMed ID: 33067551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria.
    Oladimeji O; Adepoju V; Anyiam FE; San JE; Odugbemi BA; Hyera FLM; Sibiya MN; Yaya S; Zoakah AI; Lawson L
    PLoS One; 2021; 16(1):e0244581. PubMed ID: 33471851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infection.
    Sagwa E; Ruswa N; Musasa JP; Mantel-Teeuwisse AK
    Drug Saf; 2013 Nov; 36(11):1087-96. PubMed ID: 23917883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria.
    Bajehson M; Musa BM; Gidado M; Nsa B; Sani U; Habibu AT; Aliyu I; Hussaini T; Yusuf A; Gida Y
    PLoS One; 2019; 14(11):e0225165. PubMed ID: 31743358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria.
    Adejumo OA; Olusola-Faleye B; Adepoju V; Bowale A; Adesola S; Falana A; Owuna H; Otemuyiwa K; Oladega S; Adegboye O
    Afr Health Sci; 2018 Sep; 18(3):472-478. PubMed ID: 30602977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pattern of comorbidity and its prevalence among drug-resistant tuberculosis patients at treatment initiation in Lagos, Nigeria.
    Adejumo OA; Olusola-Faleye B; Adepoju VA; Gidado M; Onoh MO; Adegboye O; Abdur-Razzaq H; Moronfolu O; Shogbamimu Y
    Trans R Soc Trop Med Hyg; 2020 Jun; 114(6):415-423. PubMed ID: 31925446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria.
    Dinic L; Akande P; Idigbe EO; Ani A; Onwujekwe D; Agbaji O; Akanbi M; Nwosu R; Adeniyi B; Wahab M; Lekuk C; Kunle-Ope C; Nwokoye N; Kanki P
    J Clin Microbiol; 2012 Sep; 50(9):2905-9. PubMed ID: 22740709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Mycobacterium Tuberculosis Positive Patients Screened for Drug-Resistant Tuberculosis at a Tertiary Health Facility in Lagos, Nigeria.
    Kuyinu YA; Odugbemi BA; Salisu-Olatunji SO; Adepoju FO; Odusanya OO
    J Natl Med Assoc; 2018 Feb; 110(1):88-91. PubMed ID: 29510850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sputum smear conversion and treatment outcomes among drug-resistant pulmonary tuberculosis patients in eastern Ethiopia: A 9-years data analysis.
    Gamachu M; Deressa A; Birhanu A; Ayana GM; Raru TB; Negash B; Merga BT; Alemu A; Ahmed F; Mohammed A; Abdulahi IM; Regassa LD
    Front Med (Lausanne); 2022; 9():1007757. PubMed ID: 36530886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality among drug-resistant tuberculosis patients in Kaduna State, Nigeria.
    Oyefabi AM; Tobin West CI; Ameh S; Jiya EN; Sadiq A; Dauda H; Onoh M
    Niger J Clin Pract; 2023 Jun; 26(6):825-831. PubMed ID: 37470659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
    Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
    Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study.
    Zhang L; Xing W; Zhou J; Zhang R; Cheng Y; Li J; Wang G; Liu S; Li Y
    BMC Infect Dis; 2020 Aug; 20(1):576. PubMed ID: 32758169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective review comparing treatment outcomes of adjuvant lung resection for drug-resistant tuberculosis in patients with and without human immunodeficiency virus co-infection.
    Alexander GR; Biccard B
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):823-8. PubMed ID: 26142471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019.
    Song WM; Guo J; Xu TT; Li SJ; Liu JY; Tao NN; Liu Y; Zhang QY; Liu SQ; An QQ; Li YF; Yu CB; Dong JH; Li HC
    BMC Pulm Med; 2021 Dec; 21(1):399. PubMed ID: 34872558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective record review of pregnant women treated for rifampicin-resistant tuberculosis in South Africa.
    Walt MV; Masuku S; Botha S; Nkwenika T; Keddy KH
    PLoS One; 2020; 15(9):e0239018. PubMed ID: 32970722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.
    Andrews JR; Shah NS; Weissman D; Moll AP; Friedland G; Gandhi NR
    PLoS One; 2010 Dec; 5(12):e15735. PubMed ID: 21209951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.